Hypoxia-induced STAT3 Contributes to Chemoresistance and Epithelial-Mesenchymal Transition in Prostate Cancer Cells.
This study suggests a new rationale for inhibiting cancer chemoresistance and EMT under hypoxia using anti-STAT3 strategies.
PMID: 25701777 [PubMed - as supplied by publisher]
Source: Biochemical and Biophysical Research communications - Category: Biochemistry Authors: Liu ZQ, Han YC, Fang JM, Hu F, Zhang X, Xu Q Tags: Biochem Biophys Res Commun Source Type: research
More News: Biochemistry | Cancer | Cancer & Oncology | Docetaxel | Epithelial Cancer | Lymphoma | Prostate Cancer | Study | Taxotere